Takeda To Launch Five Cancer, Psychoactive Drugs Over Next Three Years
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical plans a global launch over the next three years of five drugs, primarily for treating cancer and psychoactive treatments, a move away from its concentration on lifestyle-related ailments.